Pharmaceutical Products Of India Profile
Key Indicators
- Authorised Capital ₹ 70.00 Cr
- Paid Up Capital ₹ 12.03 Cr
- Company Age 38 Year, 9 Months
- Open Charges ₹ 113.89 Cr
About Pharmaceutical Products Of India
Pharmaceutical Products Of India Ltd (PPOIL) is a Public Limited Indian Non-Government Company incorporated in India on 15 May 1986 and has a history of 38 years and nine months. Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 70.00 Cr and a paid-up capital of Rs 12.03 Cr.
The company currently has active open charges totaling ₹113.89 Cr.
Company Details
- Location Mumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
L24300MH1986PLC039832
-
Company No.
039832
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
15 May 1986
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Listed
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pharmaceutical Products Of India?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Pharmaceutical Products Of India.
Enhance accessibility to Pharmaceutical Products Of India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaceutical Products Of India?
Unlock access to Pharmaceutical Products Of India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹113.89 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 91.41 Cr
- Punjab National Bank : 11.26 Cr
- Bank Of Baroda : 7.00 Cr
- State Bank Of Hyderabad : 2.00 Cr
- Industrial Development Bank Of India : 2.00 Cr
- Others : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Dec 1996 | Bank Of Baroda | ₹2.00 Cr | Open |
| 16 Nov 1995 | Punjab National Bank | ₹3.20 Cr | Open |
| 22 Apr 1995 | Punjab National Bank | ₹8.00 Cr | Open |
| 25 Mar 1995 | State Bank Of India | ₹37.58 Cr | Open |
| 18 Mar 1995 | State Bank Of India | ₹37.58 Cr | Open |
How Many Employees Work at Pharmaceutical Products Of India?
Pharmaceutical Products Of India has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaceutical Products Of India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaceutical Products Of India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.